MPower Hub: a web program to help adults manage type 2 diabetes with glucose and activity data
T4/T3 Therapy in Hypothyroidism
This project helps adults with type 2 diabetes use continuous glucose and activity tracker data alongside goal-setting tools to improve daily diabetes self-care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11296941 on NIH RePORTER |
What this research studies
You would connect your continuous glucose monitor and activity tracker to a web platform that shows easy-to-understand visualizations of your data. The platform combines those visuals with behavior-change techniques like goal setting, action planning, and prompts to increase motivation. You will report medication and self-care behaviors and choose personal goals based on your own data. The team will refine the program and test how well it supports adults with type 2 diabetes.
Who could benefit from this research
Good fit: Adults (21+) with type 2 diabetes who use or are willing to use a continuous glucose monitor and an activity tracker and want support with daily self-management.
Not a fit: People without type 2 diabetes, those unwilling to use wearable glucose or activity devices, or those seeking only medication changes are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the program could help people stick to healthier daily habits and lower blood glucose, reducing the risk of diabetes complications.
How similar studies have performed: Previous digital coaching and continuous-glucose-monitor programs have shown promise for improving behaviors and glucose control, though this specific combination of personalized visualizations and structured action-planning is relatively new.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Cappola, Anne R — University of Pennsylvania
- Study coordinator: Cappola, Anne R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.